Fiche publication
Date publication
novembre 2024
Journal
Urologic oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BARTHELEMY Philippe
Tous les auteurs :
Margue G, Klein C, Parier B, Albiges L, Pignot G, Gravis G, Bigot P, Baize N, Ingels A, Joly C, Audenet F, Vano Y, Waeckel T, Levard R, Barthelemy P, Ambrosetti D, Verkarre V, Yacoub M, Gross-Goupil M, Bernhard JC
Lien Pubmed
Résumé
Complete responses to immunotherapy in metastatic kidney cancer have led to a renewed interest in primary-site surgery. The prolonged survival of these patients has prompted consideration for nephron-sparing surgery when technically feasible. Given the surgical difficulties reported in the literature, it is essential to assess the feasibility as well as functional and oncological results of partial nephrectomy (PN) after immunotherapy.
Mots clés
Delayed surgery, Immune checkpoint inhibitor, Immunotherapy, Kidney cancer, Partial nephrectomy
Référence
Urol Oncol. 2024 11 26;:
